ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailPositive ArrowIcon Print

Hawks in Washington take aim at medical imports from China

Pandemic exposes new crack in bilateral ties after ceasefire

U.S. President Donald Trump signs a memorandum on intellectual property tariffs on China in March 2018, flanked by members of his trade team, including Commerce Secretary Wilbur Ross, second from left; U.S. Trade Representative Robert Lighthizer, and trade adviser Peter Navarro, second from right.     © Reuters

WASHINGTON -- U.S. policymakers who drove the trade war with Beijing are turning their attention from intellectual property and farm goods to medical products, as the coronavirus pandemic underscores America's reliance on China for lifesaving medical supplies.

China accounts for 18% of overall U.S. imports, but according to the Peterson Institute for International Economics, the share is 26% for medical supplies.

Sponsored Content

About Sponsored Content This content was commissioned by Nikkei's Global Business Bureau.

Discover the all new Nikkei Asia app

  • Take your reading anywhere with offline reading functions
  • Never miss a story with breaking news alerts
  • Customize your reading experience

Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.

Celebrate our next chapter
Free access for everyone - Sep. 30

Find out more